About this Event
This lecture series addresses the multifaceted journey of transforming biomedical discoveries into viable commercial ventures. We will dissect the critical business decisions that govern this process, focusing on the unique challenges and opportunities at the intersection of science and entrepreneurship. The course provides a comprehensive framework for translating a novel concept in areas such as AI diagnostics, gene therapy, or regenerative medicine into a compelling, market-ready solution.
Based on recent market analysis, the global medical devices market was valued at around $640 billion in 2024 and is projected to grow to over $1 trillion by 2034, with a compound annual growth rate (CAGR) of about 6.5%. Regions like North America currently hold a significant market share, but the Asia-Pacific region, particularly India, is emerging as a major growth driver. India's medtech sector, for example, is expected to outpace global growth, with projections to reach $50 billion by 2030.
In this -VIRTUAL- lecture, you will learn to navigate the core pillars of a biomedical startup:
Regulatory Framework & Market Access: Examine the rigorous regulatory pathways, from initial submission to clinical trial design and management, essential for bringing a product to market. We will explore the critical oversight required to ensure both safety and efficacy.
Capitalization & Financial Strategy: Develop a comprehensive financial strategy tailored to the high costs and protracted timelines of biomedical R&D. We will explore key funding sources, including venture capital, strategic partnerships, and government grants.
Intellectual Property Management: Explore the fundamentals of intellectual property protection, including patents, trademarks, and trade secrets, to establish a defensible competitive advantage in a complex market.
Organizational Development & Leadership: Understand the principles of building and leading a high-performing, multidisciplinary team capable of navigating the scientific, engineering, and business challenges inherent to a startup.
This lecture series provides a comprehensive framework for aspiring entrepreneurs, equipping them with the knowledge to build resilient and impactful biomedical companies that shape the future of healthcare.
Reading Appetizer from yours truly:
The Future of Pathology: How AI is Redefining the Pathologist's Role
Event Venue & Nearby Stays
Palo Alto, United States
USD 77.77 to USD 99.99
